Number of nucleated cells infused during allogeneic and autologous bone marrow transplantation: An important modifiable factor influencing outcome [3]

Blood

Volumn 90, Issue 9, 1997, Pages 3808-3810

  Mehta, J ^a   Powles, R ^a   Treleaven, J ^a   Kulkarni, S ^a   Horton, C ^a   Singhal, S ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MELPHALAN;

ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLEEDING; CANCER CHEMOTHERAPY; CELL NUCLEUS; GRAFT FAILURE; HUMAN; INFECTION; LETTER; LEUKEMIA; LEUKOCYTE COUNT; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0030736626     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3808     Document Type: Letter

References (15)